The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 30, 2002

Filed:

Jun. 29, 1999
Applicant:
Inventors:

Kamel Mabrouk, Marseilles, FR;

Jean-Marc Sabatier, Chateauneuf-le-Rouge, FR;

Herve Rochat, Mimet, FR;

Jurphaas Van Rietschoten, Aix-en-Provence, FR;

Assignee:

Gellpep S.A., Paris, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 4/500 ;
U.S. Cl.
CPC ...
A61K 4/500 ;
Abstract

Multiple branch peptide constructions formed from peptides derived from the envelope transmembrane glycoprotein gp41 of HIV, and including the consensus sequence RQGY preceded by 0 to 4 amino acid residues and succeeded by 2 to 4 amino acid residues, most preferably RQGYSPL, show increased receptor affinity and prevent cell-to-cell fusion. They have a direct virostatic effect. Because they present the same peptide sequence several times, these MBPCs are able to neutralize in vitro the different steps of virus envelope/cell membrane fusion, and infected cell membrane/uninfected cell membrane fusion of several strains of HIV-1 and HIV-2. These results open a potential use in treatment of HIV infection.


Find Patent Forward Citations

Loading…